Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S.

August 21st, 2014 ITI moves one step closer to a solution for the worldwide allergy crisis DNA vaccine pioneer Immunomic Therapeutics, Inc.(ITI) is making progress in its development of JRC-LAMP-vax, an innovative and safe potential treatment for allergy to Japanese red cedar pollen. Phase IC studies began this month in Hawaii, moving the world closer to a real solution to hay …